← The Wire
CVKDNasdaq
Cadrenal Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1937993
Advancing novel therapies for life-threatening immune and thrombotic conditions, focusing on CAD-1005 for HIT
red 8-K · 90d
$11M
Market cap
$3.02
Last close
-1.0%
1D
-5.0%
5D
33K
Volume
Price · last 39 sessions-54.3%
May 4L $2.86 · H $6.61Jun 29
98
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KExecutive ChangeJun 29, 20268-KReg FD Disclosure · Company UpdateJun 18, 20268-KExecutive ChangeJun 3, 20268-KResults of OperationsMay 7, 202610-QQUARTERLY REPORTMay 7, 20268-KReg FD Disclosure · Company UpdateApr 30, 20268-KMaterial Agreement · Equity IssuanceApr 1, 2026424B5PROSPECTUS SUPPLEMENTApr 1, 202610-KANNUAL REPORTMar 31, 20268-KResults of OperationsMar 31, 20268-KReg FD Disclosure · Company UpdateMar 12, 20268-KCompany UpdateFeb 24, 2026S-1REGISTRATION STATEMENTDec 29, 20258-KCompany UpdateDec 23, 2025424B5PROSPECTUS SUPPLEMENTDec 23, 20258-KMaterial Agreement · Equity IssuanceDec 16, 2025424B5PROSPECTUS SUPPLEMENTDec 16, 2025424B5PROSPECTUS SUPPLEMENTDec 16, 20258-KMaterial Agreement · Reg FD DisclosureDec 11, 20258-KExecutive Change · Company UpdateDec 1, 20258-KCompany UpdateNov 18, 2025424B5PROSPECTUS SUPPLEMENTNov 18, 20258-KResults of OperationsNov 10, 202510-QQUARTERLY REPORTNov 10, 20258-KShareholder VoteSep 24, 20258-KMaterial Agreement · Reg FD DisclosureSep 15, 20258-KResults of OperationsAug 11, 202510-QQUARTERLY REPORTAug 11, 20258-KCompany UpdateAug 5, 2025DEFA14ADEFINITIVE ADDITIONAL MATERIALSJul 31, 2025DEF 14APROXY STATEMENTJul 31, 20258-KExecutive Change · Company UpdateJul 18, 20258-KResults of OperationsMay 8, 202510-QQUARTERLY REPORTMay 8, 20258-KCompany UpdateApr 17, 2025424B5PROSPECTUS SUPPLEMENTApr 17, 20258-KResults of OperationsMar 13, 202510-KANNUAL REPORTMar 13, 20258-KMaterial Agreement · Company UpdateMar 4, 20258-KExecutive Change · Company UpdateFeb 7, 2025424B5PROSPECTUS SUPPLEMENTDec 20, 202410-QQUARTERLY REPORTNov 7, 20248-KResults of OperationsNov 7, 20248-KMaterial Agreement · Equity IssuanceNov 4, 2024424B5PROSPECTUS SUPPLEMENTNov 4, 20248-KReg FD Disclosure · Company UpdateOct 24, 2024SC 13GSCHEDULE 13GOct 4, 20248-KReg FD Disclosure · Company UpdateSep 25, 20248-KDelisting NoticeSep 5, 20248-KSecurity-Holder Rights · Bylaw AmendmentAug 20, 20248-KSecurity-Holder Rights · Bylaw AmendmentAug 16, 20248-KResults of OperationsAug 8, 202410-QQUARTERLY REPORTAug 7, 20248-KReg FD Disclosure · Company UpdateAug 6, 20248-KExecutive Change · Shareholder VoteJul 31, 2024DEFA14ADEFINITIVE ADDITIONAL MATERIALSJun 12, 2024DEF 14APROXY STATEMENTJun 11, 202410-QQUARTERLY REPORTMay 9, 20248-KCompany UpdateMay 9, 20248-KReg FD Disclosure · Company UpdateApr 9, 20248-KMaterial AgreementMar 12, 20248-KResults of OperationsMar 11, 202410-KANNUAL REPORTMar 11, 20248-KDelisting NoticeMar 5, 20248-K/ADelisting NoticeFeb 15, 2024SC 13GSC 13GFeb 14, 2024SC 13GSCHEDULE 13GFeb 12, 20248-KExecutive Change · Company UpdateFeb 12, 20248-KResults of OperationsNov 9, 202310-QQUARTERLY REPORTNov 9, 20238-KShareholder VoteOct 23, 20238-KDelisting NoticeSep 8, 2023DEFA14ADEFINITIVE ADDITIONAL MATERIALSAug 31, 2023DEFA14ADEFINITIVE ADDITIONAL MATERIALSAug 31, 2023DEF 14ADEFINITIVE PROXY STATEMENTAug 28, 20238-KReg FD DisclosureAug 18, 20238-KCompany UpdateAug 16, 20238-KResults of OperationsAug 10, 202310-QQUARTERLY REPORTAug 10, 20238-KExecutive Change · Company UpdateJul 24, 2023
Insider Activity
In the 90 days to Dec 29, 2025: 2 sold $298K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 29, 2025 | Szot Matthew KChief Financial Officer | Sell | 9,933 | $6.97 | $69K |
| Oct 27, 2025 | Szot Matthew KChief Financial Officer | Sell | 1,800 | $13.99 | $25K |
| Oct 27, 2025 | Pham Quang XCEO and Chairman | Sell | 1,315 | $13.99 | $18K |
| Oct 24, 2025 | Szot Matthew KChief Financial Officer | Sell | 1,800 | $13.99 | $25K |
| Oct 24, 2025 | Pham Quang XCEO and Chairman | Sell | 1,129 | $14.03 | $16K |
| Oct 13, 2025 | Pham Quang XCEO and Chairman | Sell | 1,800 | $14.15 | $25K |
| Oct 13, 2025 | Szot Matthew KChief Financial Officer | Sell | 1,800 | $14.07 | $25K |
| Oct 9, 2025 | Pham Quang XCEO and Chairman | Sell | 1,800 | $14.02 | $25K |
| Oct 9, 2025 | Szot Matthew KChief Financial Officer | Sell | 1,693 | $13.99 | $24K |
| Oct 6, 2025 | Szot Matthew KChief Financial Officer | Sell | 107 | $13.99 | $1K |
| Oct 2, 2025 | Pham Quang XCEO and Chairman | Sell | 500 | $14.13 | $7K |
| Oct 1, 2025 | Szot Matthew KChief Financial Officer | Sell | 1,700 | $13.99 | $24K |
| Oct 1, 2025 | Pham Quang XCEO and Chairman | Sell | 881 | $14.01 | $12K |
| Sep 29, 2025 | Pham Quang XCEO and Chairman | Sell | 419 | $14.01 | $6K |
| Sep 29, 2025 | Szot Matthew KChief Financial Officer | Sell | 100 | $14.00 | $1K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance